INTERCEPT PHARMACEUTICALS, INC. Zu einer Liste hinzufügen
Terminchart Intercept Pharmaceuticals, Inc.
b.wFjhc2_taMHxM66lRyhE-5uX-AZ23AVXMle3LRDH1v0.hi2IPj_UMIW8AtrydRgNmqj9tUFEtH8OaznbRiiA5Yz3PYdDX7kboKFclg~76d463bfc29b8109d8a867e6ccd04c8d
Anstehende Termine für Intercept Pharmaceuticals, Inc.
Zurückliegende Termine für Intercept Pharmaceuticals, Inc.
| 13.11.2023 19:00 | American Association for the Study of Liver Diseases Conference - Poster Number #4545-C |
| 13.09.2023 21:10 | Baird Global Healthcare Conference |
| 11.09.2023 17:00 | H.C. Wainwright Global Investment Conference |
| 02.08.2023 14:30 | Q2 2023 Präsentation des Ergebnisses |
| 02.08.2023 13:00 | Q2 2023 Ergebnisveröffentlichung |
| 24.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2443 |
| 23.06.2023 14:30 | OCA FDA Approval Call |
| 23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2321 |
| 23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #2349 |
| 23.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1518 |
| 23.06.2023 08:45 | European Association for the Study of the Liver Congress - Abstract #2495 |
| 21.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1522 |
| 21.06.2023 09:00 | European Association for the Study of the Liver Congress - Abstract #1505 |
| 21.06.2023 | European Association for the Study of the Liver Congress |
| 07.06.2023 | Jefferies Global Healthcare Conference |
| 24.05.2023 20:00 | Jahreshauptversammlung |
| 19.05.2023 | Gastrointestinal Drugs Advisory Committee Meeting |
| 27.04.2023 14:00 | Q1 2023 Präsentation des Ergebnisses |
| 27.04.2023 13:00 | Q1 2023 Ergebnisveröffentlichung |
| 14.03.2023 | Barclays Global Healthcare Conference |
Mehr Termine
